Hypercholesterolemia impairs angiogenesis in patients with breast carcinoma and, therefore, lowers the risk of metastases

American Journal of Clinical Pathology

Volumn 122, Issue 5, 2004, Pages 696-703

  Özdemir, Binnaz Handan ^a,b   Akcali, Zafer ^a   Haberal, Mehmet ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Angiogenesis; Basic fibroblast growth factor; bFGF; Breast; Hypercholesterolemia; Metastasis; Outcome; Recurrence; Vascular endothelial growth factor; VEGF

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CHOLESTEROL; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; CANCER RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HUMAN; HYPERCHOLESTEROLEMIA; INHIBITION KINETICS; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT;

EID: 7244238191     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/HW2MYB5TVF4AM0Y4     Document Type: Article

References (44)

1. Folkman J, Watson K, lngber D, et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature. 1989;339:58-61.
2. Folkman J. Angiogenesis and breast cancer. J Clin Oncol. 1994;12:441-443.
3. Plate KH, Breier G, Welch HA, et al. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature. 1992;359:845-848.
4. Conn G, Soderman DD, Schaeffer MT, et al. Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc Natl Acad Sci U S A. 1990;87:1323-1327.
5. Breier G, Albrecht U, Sterrer S, et al. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development. 1992;114:521-532.
6. Shweiki D, Irin A, Soffer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843-845.
7. Hasebe T, Imoto S, Sasaki S, et al. Proliferative activity and tumor angiogenesis is closely correlated to stromal cellularity of fibroadenoma: proposal fibroadenoma, cellular variant. Pathol Int. 1999;49:435-443.
8. Faridi A, Rudlowski C, Biesterfeld S, et al. Long-term follow-up and prognostic significance of basic fibroblast growth factor (bFGF) expression in patients with breast cancer. Pathol Res Pract. 2002;198:1-5.
9. Henry PD. Hypercholesteroletnia and angiogenesis. Am J Cardiol. 1993;72:61C-64C.
10. Tobelem G. Endothelial cell growth: biology and pharmacology in relation to angiogenesis. Blood Coagul Fibrinolysis. 1990;1:703-705.
11. Bucay M, Nguy J, Barrious R, et al. Impaired adaptive vascular growth in hypercholesterolemic rabbit. Atherosckrosis. 1998;139:243-251.
12. Duan J, Murohara T, Ikeda H, et al. Hypercholesterolemia inhibits angiogenesis in response to hind limb ischemia. Circulation. 2000;102(suppl III):370-376.
13. Chen CH, Henry PD. Atherosclerosis as a microvascular disease: impaired angiogenesis mediated by suppressed basic fibroblast growth factor expression. Proc Assoc Am Physicians. 1997;109:351-361.
14. Frierson HF Jr, Wolber RA, Berean KW, et al. Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol. 1995;103:195-198.
15. Henricksson P, Eriksson M, Ericsson R, et al. Hypocholesterolaemia and increased elimination of low-density lipoproteins in metastatic cancer of the prostate. Lancet. 1989;2:1178-1180.
16. Cambien F, Ducimetiere P, Richard J. Total serum cholesterol and cancer mortality in a middle-aged male population. Am J Epidemiol. 1980;112:388-394.
17. Sherwin RW, Wentworth DN, Cutter JA, et al. Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial. JAMA. 1987;257:943-948.
18. Rose G, Shipley MJ. Plasma lipids and mortality: a source of error. Lancet. 1980;1:523-526.
19. Feinleib M. Review of the epidemiological evidence for a possible relationship between hypocholesterolemia and cancer. Cancer Res. 1983;43:2503-2507.
20. Sidney S, Farquahar JW. Cholesterol, cancer and public health policy. Am J Med. 1983;75:494-508.
21. Williams RR, Sorlie PD, Feinleib M, et al. Cancer incidence by levels of cholesterol. JAMA. 1981;245:247-252.
22. Kagan A, McGee DL, Yano K, et al. Serum cholesterol and mortality in a Japanese-American population: the Honolulu Heart Program. Am J Epidemiol. 1981;114:11-20.
23. Kozarevic DJ, McGee D, Vojvodic N, et al. Serum cholesterol and mortality: the Yugoslavia Cardiovascular Disease Study. Am J Epidemiol. 1981;114:21-28.
24. Garcia-Palmieri MR, Sorlie PD, Costas R, et al. An apparent inverse relationship between serum cholesterol and cancer mortality in Puerto Rico, Am J Epidemiol. 1981;114:29-40.
25. Morris DL, Borhani NO, Fitzsimons E, et al. Serum cholesterol and cancer in the Hypertension Detection and Follow-up Program. Cancer. 1983;52:1754-1759.
26. Kark JD, Smith AH, Hames CG. The relationship of serum cholesterol to the incidence of cancer in Evans County, Georgia. J Chronic Dis. 1980;33:311-332.
27. Wallace RB, Rost C, Burmeister LF, et al. Cancer incidence in humans: relationship to plasma lipids and relative weight. J Natl Cancer Inst. 1982;68:915-918.
28. Keys A, Aravanis C, Blackburn H, et al. Serum cholesterol and cancer mortality in the Seven Countries Study. Am J Epidemiol. 1985;121:870-883.
29. Beaglehole R, Foulkes MA, Prior IA, et al. Cholesterol and mortality in New Zealand Maoris. Br Med J. 1980;280:285-287.
30. Vitols S, Gahrton G, Öst A, et al. Elevated low-density lipoprotein receptor activity in leukemic cells with monocytic differentiation. Blood. 1984;63:1186-1193.
31. Vitols S, Gahrton G, Björkholm M, et al. Hypocholesterolaemia in malignancy due to elevated low-density lipoprotein-receptor activity in tumor cells: evidence from studies in leukemic patients. Lancet. 1985;2:1150-1154.
32. Goldstein JL, Brown MS. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem. 1977;46:897-930.
33. Gasparini G, Harris A. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol. 1995;13:765-782.
34. Gunel N, Akcali Z, Coskun U, et al. Prognostic importance of tumor angiogenesis in breast carcinoma with adjuvant chemotherapy. Pathol Res Pract. 2002;198:7-12.
35. Jacquemier JD, Panault-Llorca FM, Bertucci F, et al. Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis. J Pathol. 1998;184:130-135.
36. Murugesan G, Fox PL. Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low-density lipoprotein. J Clin Invest. 1996;97:2736-2744.
37. Chen CH, Cartwright J Jr, Li Z, et al. Inhibitory effects of hypercholesterolemia and oxidized LDL on angiogenesis-like endothelial growth in rabbit aortic explants: essential role of basic fibroblast growth factor. Arterioscler Thromb Vasc Biol. 1997;17:1303-1312.
38. Ambs S, Merriam WG, Ogunfusika MO, et al. p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells. Nat Med. 1998;4:1371-1376.
39. Ambs S, Merriam WG, Bennett WP, et al. Frequent nitric oxide synthase-2 in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 1998;58:334-341.
40. Dulak J, Jozkowicz A. Regulation of vascular endothelial growth factor synthesis by nitric oxide: facts and controversies. Antioxid Redox Signal. 2003;5:123-132.
41. Chin K, Kurashima Y, Ogura T, et al. Induction of vascular endochelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells. Oncogene. 1997;15:437-442.
42. Frank S, Stallmeyer B, Kampfer H, et al. Differential regulation of vascular endothelial growth factor and its receptor fms-like tyrosine kinase is mediated by nitric oxide in rat mesangial cells. Biochem J. 1999;338:367-374.
43. Turpaev K, Litvinov D, Dubovaya V, et al. Induction of vascular endothelial growth factor by nitric oxide in cultured human articular chondrocytes. Biochimie. 2001;83:515-522.
44. Jang JJ, Ho H, Kwan HH, et al. Angiogenesis is impaired by hypercholesterolemia: role of asymmetric dimethylarginine. Circulation. 2000;102:1414-1419.